SEC Form 4 · accession 0001225208-18-003963
PFIZER INC · PFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Loretta V Cangialosi
Officer — Sr. Vice President, Controller
Period of report
Feb 22, 2018
Accepted (ET)
Feb 23, 2018 · 3:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000078003
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 22, 2018 | A | 4,166 | $0.00 | A | 88,481 | D | |
| Common Stock | holding | — | — | — | 1,574 | I | By Rule 16b-3 Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF2 | $35.74 | Feb 22, 2018 | A | 21,673 | A | Feb 22, 2023 | Feb 22, 2023 | Common Stock | 21,673 | 21,673 | D |
| Stock Appreciation RightsF3 | $35.74 | Feb 22, 2018 | A | 18,119 | A | Feb 22, 2025 | Feb 22, 2025 | Common Stock | 18,119 | 18,119 | D |
Explanation of responses
- F1The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
- F2The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
- F3The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.